223
The initial preclinical trials have shown promising results, demonstrating the nanobots’ ability to selectively destroy cancer cells without harming surrounding healthy tissue. The research team is now preparing for the next phase of trials to assess the technology’s safety and efficacy in human subjects.
If successful, this nanotechnology could mark a significant leap forward in the fight against cancer, offering hope for more effective and less invasive treatment options.
